News Pressure BioSciences Updates Stakeholders with Solid Progress on Key 2022 Goals: UST Commercial Release, Major Revenue Increase, Continued Financial Position Improvement, and Planned Uplist Mar 17, 2022 Posted by Pressure BioSciences, Inc.
News Introducing Lumanity – An Organization Dedicated to Accelerating and Optimizing Access to Medical Advances Mar 16, 2022
News EdiGene Obtains Worldwide License from Boston Children’s Hospital to Methods and Compositions for Increasing Fetal Hemoglobin Levels to Treat Hemoglobinopathies Mar 16, 2022
News Digital Health Compliance Considerations — Revenue Models and Patient Incentives Mar 15, 2022 Posted by Sidley Austin
News Morningside Ventures Launches Adiso Therapeutics to Advance Novel Therapies for Inflammatory Diseases Mar 11, 2022 Posted by Adiso Therapeutics, Inc.
News Emerging Technology Insider Releases a New TechTalks Video Interview Featuring Richard T. Schumacher, CEO and Founder of Pressure BioSciences, Inc. Mar 10, 2022 Posted by Pressure BioSciences, Inc.
News Aurobindo Pharma Arrives in Puerto Rico as Auro PR, Inc. to Expand the Island’s Pharma Capabilities Mar 08, 2022 Posted by Invest Puerto Rico